CEACAM1 and fatty liver disease: Our data demonstrated that whereas the loss of CEACAM1 in hepatocytes causes hyperinsulinemia-driven hepatic insulin resistance and steatosis in addition to hepatic inflammation and fibrosis, its endothelial loss causes inflammation-driven hepatic fibrosis in the absence of insulin resistance and hepatic steatosis.